目的:探讨Rood疗法联合家庭肺康复对老年特发性肺纤维化(IPF)患者呼吸功能和活动能力的影响。方法:选取21例IPF患者,按照干预方法分为对照组和观察组,所有患者接受抗纤维化药物治疗和家庭肺康复训练,观察组额外接受Rood刺激疗法。评估两组患者在治疗前,治疗第12周和第24周的FEV1% pred、6MWT距离和SGRQ评分。结果:干预后,两组患者组内前后测FEV1% pred、6MWT和SGRQ评分均较治疗前有所改善。组间测试干预12周后,观察组的FEV1% pred与对照组相比有显著差异(P = 0.020),24周后差异更为显著(P = 0.004)。6MWT和SGRQ评分在组间后测中无明显差异。结论:Rood疗法联合家庭肺康复可有效提升IPF患者的肺通气能力,对提高有氧活动能力和生活质量具有积极作用,有助于延缓病情进展。 Objective: To explore the effects of Rood therapy combined with home pulmonary rehabilitation on respiratory function and activity capacity in elderly patients with idiopathic pulmonary fibrosis (IPF). Methods: Twenty-one IPF patients were retrospectively enrolled and stratified into control and observation groups based on therapeutic interventions. All patients received antifibrotic agents and home-based pulmonary rehabilitation therapy;the observation group additionally underwent Rood stimulation therapy. The forced expiratory volume in one second percentage predicted (FEV1% pred), 6-minute walk test (6MWT) distance, and St. George’s Respiratory Questionnaire (SGRQ) scores were assessed for both groups before treatment and at the 12 and 24 weeks post-treatment. Results: Post-intervention, both groups showed improvements in FEV1% pred, 6MWT, and SGRQ scores compared to pre-treatment. Between-group testing at 12 weeks post-intervention revealed a significant difference in FEV1% pred between the observation and control groups (P = 0.020), with an even more pronounced difference at 24 weeks (P = 0.004). No significant differences were observed in 6MWT and SGRQ sc
